SCHEMBL24333634

SCHEMBL24333634

COC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C(C)C1C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 3/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ DOT1L Q8TEK3 2/20 0.52
▸ DNPH1 O43598 1/20 0.52
▸ PRKAB2 O43741 1/20 0.52
▸ TRPM2 O94759 1/20 0.52
▸ LDHA P00338 1/20 0.52
▸ ADRB2 P07550 1/20 0.52
▸ FBP1 P09467 1/20 0.52
▸ SRC P12931 1/20 0.52
▸ P2RY2 P41231 1/20 0.52
▸ P2RY1 P47900 1/20 0.52
▸ PRKAG1 P54619 1/20 0.52
▸ PRKAA2 P54646 1/20 0.52
▸ PDE4D Q08499 1/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ PRKAA1 Q13131 1/20 0.52
▸ PDE3A Q14432 1/20 0.52
▸ TAS1R3 Q7RTX0 1/20 0.52
▸ TAS1R1 Q7RTX1 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18521950 0.88 ADORA3 (0.56) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL26505475 0.81 ADORA3 (0.53) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL15788449 0.80 ADORA1 (0.74) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL15338536 0.80 ADORA1 (0.74) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL15926827 0.80 ADORA1 (0.74) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL384075 0.80 ADORA1 (0.74) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL15338502 0.80 ADORA1 (0.74) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL41361 0.80 ADORA1 (0.74) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL21999054 0.80 ADORA3 (0.56) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2
SCHEMBL12376385 0.80 ADORA3 (0.56) ADORA1SMN1; SMN2DOT1LDNPH1PRKAB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220118055-A1 RELEASABLE GLP-1 CONJUGATES FISH & RICHARDSON PC 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220118055-A1 RELEASABLE GLP-1 CONJUGATES GLP1R, GIPR, IAPP ADORA1 313/4885SMN1; SMN2 1974/4885DOT1L 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback